Sarepta Therapeutics | SRPT - Eps Gewinn Pro Aktie

Aktienkurs
20.30
Täglich Wechseln
-0.12 -0.59%
Monatlich
-14.60%
Jährlich
-66.41%
Q2 Prognose
19.87

Fiscal Kalender Aktuell Konsens Zuletzt Datum
FY2026Q1 Mar/2026 1.11 -3.42 May/06
FY2025Q4 Dec/2025 -3.58 -1.27 1.90 Feb/25
FY2025Q3 Sep/2025 -0.13 -0.6 0.62 Nov/03
FY2025Q2 Jun/2025 2.02 0.98 0.44 Aug/06
FY2025Q1 Mar/2025 -3.42 1.93 0.73 May/06




Eps Veränderung Datum
Acadia Pharmaceuticals USD 1.6 1.18 2025-12
Agios Pharmaceuticals USD -1.86 0.08 2025-12
Alnylam Pharmaceuticals USD 1.25 1.65 2025-12
Amgen USD 5.29 0.35 2025-12
BioCryst Pharmaceuticals USD 1.17 1.1 2025-12
Biogen USD 1.99 2.82 2025-12
BioMarin Pharmaceutical USD 0.46 0.34 2025-12
Capricor Therapeutics USD -0.62 0.08 2025-12
Daiichi Sankyo JPY 46.79 22.27 2025-12
Eli Lilly USD 7.54 0.52 2025-12
Esperion Therapeutics USD 0.26 0.42 2025-12
Gilead Sciences USD 1.86 0.61 2025-12
Incyte USD 1.8 0.46 2025-12
Insmed USD -1.54 0.21 2025-12
Ionis Pharmaceuticals USD -1.41 0.61 2025-12
Moderna USD -2.11 1.6 2025-12
Nektar Therapeutics USD -1.35 1.17 2025-12
Neurocrine Biosciences USD 1.88 0.29 2025-12
Novavax USD 0.13 0.59 2025-12
Pfizer USD 0.66 0.21 2025-12
PTC Therapeutics USD -1.67 1.87 2025-12
Regeneron Pharmaceuticals USD 11.44 0.39 2025-12
Roche Holding CHF 8.37 2.95 2025-12
Sangamo BioSciences USD -0.18 0.1 2024-06
Sanofi EUR 1.88 0.35 2026-03
Sarepta Therapeutics USD -3.58 3.45 2025-12
Tectonic Therapeutic USD -1.03 0.01 2025-12
Ultragenyx Pharmaceutical USD -1.29 0.52 2025-12
Vertex Pharmaceuticals USD 5.03 0.23 2025-12